Insights On Partnering

31. 2025 Clinical Trial Payment Tax Implications Explained 10/8/2025

    Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

32. Bridging The Engagement Gap In Obesity Trials 2/13/2026

    Improve obesity trial retention with actionable guidance: provide proactive plateau counseling, simplify data capture, and leverage existing provider-patient relationships to sustain motivation.

33. PCI Pharma Services Capacity Update July 2025: Fill/Finish 7/28/2025

    PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with cutting-edge technology, and innovative solutions for high-value biologics, complex formulations, and lyophilized drug products.

34. Development And Manufacture Of A Highly Potent OSD Product 10/20/2025

    Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

35. The Case For Parallel Processing In Clinical Trial Start-Up 1/26/2026

    Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.

36. Australia's Edge In Oncology And Nuclear Medicine Trials 11/21/2025

    Discover how we leverage Australia’s world-class clinical infrastructure, streamlined regulatory environment, and early-phase expertise to accelerate oncology and nuclear medicine trials.

37. Big Futures For Emerging Biopharma: Navigating Biotech Hurdles 1/14/2026

    Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.

38. Full Patient Journey Data A Must For Clinical Planning 3/9/2026

    Move beyond fragmented trial planning by using longitudinal patient insights to optimize protocols, improve site selection, and overcome recruitment hurdles for more predictable outcomes.

39. How Real-World Data On Site Costs Accelerates Clinical Trial Success 10/23/2025

    Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

40. Biometric Services For Large Pharmaceutical Company 7/31/2025

    This case exemplifies the effectiveness of flexible staffing solutions in meeting the dynamic needs of the biopharmaceutical industry while maintaining control over project deliverables and timelines.